Biotechnology advances the plastics industry by employing living cells and enzymes to create eco-friendly solutions and ...

This pharmaceutical biotechnology company announced a significant milestone in its global intellectual property strategy. The ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether BioCryst Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Peter Marks, the venerable head of the FDA’s Center for Biologics Evaluation and Research, has been forced out. In this ...

The new rule only applies to new shops, and it only targets stores whose primary product is vape and tobacco products.

A group of experts cautions that the lack of specific rules for genome-edited crops may hurt transparency, while the ...

Gyre Therapeutics ("Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced financial results for the first quarter ended March 31, 2025 ...

The United States is India's largest trading partner, with bilateral trade totalling some $129 billion in 2024. The trade ...

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.

Generated record quarterly net revenues of $197.1 million, representing year-over-year growth of 43.4%Total Rare Disease quarterly net revenues of $69.0 million, which includes:Purified Cortrophin® Ge ...

Rocket Lab will continue to benefit from its NSSL Phase 3 contract and Mynaric acquisition. Read more on this company's ...